Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Thomas K Karikari¹, Augustina Charway-Felli², Kina Höglund^{3

4}, Kaj Blennow^{3

4}, Henrik Zetterberg^{3

4

5

6}

Affiliations

¹ School of Life Sciences, Midlands Integrative Biosciences Training Partnership, University of Warwick, Coventry, United Kingdom.
² Neurology Department, 37 Military Hospital, Accra, Ghana.
³ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, The University of Gothenburg, Mölndal, Sweden.
⁴ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
⁵ Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
⁶ UK Dementia Research Institute at UCL, London, United Kingdom.

Comment

Thomas K Karikari et al. Front Neurol. 2018.

. 2018 Mar 29:9:201.

doi: 10.3389/fneur.2018.00201. eCollection 2018.

Thomas K Karikari¹, Augustina Charway-Felli², Kina Höglund^{3

4}, Kaj Blennow^{3

4}, Henrik Zetterberg^{3

4

5

6}

¹ School of Life Sciences, Midlands Integrative Biosciences Training Partnership, University of Warwick, Coventry, United Kingdom.
² Neurology Department, 37 Military Hospital, Accra, Ghana.
³ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, The University of Gothenburg, Mölndal, Sweden.
⁴ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
⁵ Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
⁶ UK Dementia Research Institute at UCL, London, United Kingdom.

No abstract available

Keywords: Alzheimer’s disease; biomarkers; dementia; low- and middle-income countries; neurodegenerative diseases.

Comment on

Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
GBD 2015 Neurological Disorders Collaborator Group. GBD 2015 Neurological Disorders Collaborator Group. Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17. Lancet Neurol. 2017. PMID: 28931491 Free PMC article.

1. World Health Organization. World Report on Ageing and Health. (2015). Available from: http://www.who.int/ageing/events/world-report-2015-launch/en/. (accessed November 21, 2017).
1. GBD 2015 Neurological Disorders Collaborator Group. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol (2017) 16:877–97.10.1016/S1474-4422(17)30299-5 - DOI - PMC - PubMed
1. Olayinka OO, Mbuyi NN. Epidemiology of dementia among the elderly in Sub-Saharan Africa. Int J Alzheimers Dis (2014) 2014:e195750.10.1155/2014/195750 - DOI - PMC - PubMed
1. Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol (2016) 15:673–84.10.1016/S1474-4422(16)00070-3 - DOI - PubMed
1. Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, et al. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol (2009) 9:63.10.1186/1471-2377-9-63 - DOI - PMC - PubMed